4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001172252-26-000002
Director acquired 11,580 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SCHIFF ANDREW N Director | 2026-06-05 | Option exercise | +11,580 | 25,540 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| SCHIFF ANDREW N Director | 2026-06-04 | Grant or award · Stock Option (Right to Buy) | +42,350 | 42,350 | D: show line 2 in the form | |||||
| SCHIFF ANDREW N Director | 2026-06-04 | Grant or award · Restricted Stock Units | +10,987 | 10,987 | D: show line 3 in the form | |||||
| SCHIFF ANDREW N Director | 2026-06-05 | Option exercise · Restricted Stock Units | −11,580 | 0 | D: show line 4 in the form |
Loading xslF345X06/form4-06082026_040612.xml…